Why Canopy Growth Corp (TSX:WEED) Is Still Top of the Class

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) keeps racking up wins in the marijuana industry. How long can the company keep going?

| More on:
Gold medal

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Canopy Growth (TSX:WEED)(NYSE:CGC) has been one of the biggest winners of the recent explosion of the cannabis market. The company’s share price has increased at a dizzying pace over the past five years.

Canopy is now the biggest pot company in the world by market cap, and with a high production capacity, about 30% of the domestic market share, and strong international operations, it is hard to bet against the marijuana giant. Canopy recently made several moves that are likely to keep investors’ enthusiasm high. Let’s see what the Ontario-based pot grower has been up to.

Updated guidance

Canopy made headlines last week during the GMP Securities cannabis conference in Toronto. The CEO of the company — Bruce Lipton — announced the acquisition of the Spanish cannabis company Cafina. This acquisition bolsters Canopy’s international presence, which is already very strong compared to that of most of its peers. But that wasn’t it for Canopy.

The company also announced an updated guidance that left investors licking their fingers. According to the CEO, Canopy expects at least $744 million in revenues during the current fiscal year, which is much higher than most analysts’ estimates.

While the company likely won’t be profitable yet, choosing to continue aggressively pursuing expansion projects, Canopy’s revenue is a strong indication of its current place in the cannabis industry. During the last quarter, the Ontario-based firm was second to none in terms of sales, beating its closest rival by about $30 million.

Another acquisition

Canopy made yet another move last week. The company is reportedly on the verge of acquiring Acreage Holdings, one of the largest vertically integrated cannabis company in the U.S. Despite marijuana still being illegal at the federal level south of the border, the U.S. is the largest cannabis market in the world.

While the hemp market suddenly became more attractive last year once legislation was passed that made it legal (and Canopy plans on entering said market via a licence it acquired in New York), acquiring a well-established cannabis company operating in the U.S. would be an even better way for Canopy to dip its toes in the water. Shares of Canopy jumped by as much as 10% on the heels of its potential deal with Acreage Holdings.

Should you buy?

Canopy looks increasingly likely to be the dominant force in the marijuana market for years to come. In addition to its strong domestic and international operations and high production capacity, the company is now looking to enter the U.S. market in a big way. If this deal pans out, Canopy’s share value will likely reach new heights.

Let’s not forget the firm’s secret weapon: boatloads of cash to fund its growth via its partnership with Constellation Brands. Unlike some of its competitors, Canopy no longer has to rely on dilutive forms of financing to expand its production capacity or make new acquisitions. Canopy is already up by more than 50% this year. There is likely more coming, and now may be a good time to jump on the bandwagon.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Prosper Bakiny has no position in any of the companies mentioned. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »